《医疗器械临床试验机构条件和备案管理办法》解读

2017-11-25 佚名 医药界

近日,食品药品监管总局会同国家卫生计生委联合发布《医疗器械临床试验机构条件和备案管理办法》(以下简称《备案办法》),将于2018年1月1日起施行。

近日,食品药品监管总局会同国家卫生计生委联合发布《医疗器械临床试验机构条件和备案管理办法》(以下简称《备案办法》),将于2018年1月1日起施行。

一、《备案办法》制定背景

按照中共中央办公厅和国务院办公厅印发的《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》(厅字〔2017〕42号)和《国务院关于修改〈医疗器械监督管理条例〉的决定》(中华人民共和国国务院令第680号)要求,对医疗器械临床试验机构实行备案管理。为了落实国务院简政放权、放管结合、优化服务的精神,深入推进医疗器械审评审批制度改革,鼓励更多具有优质资源的医疗机构参与医疗器械临床试验,强化申办者责任,规范医疗器械临床试验过程,食品药品监管总局会同国家卫生计生委经公开征求意见,反复修改,制定了《备案办法》。

二、《备案办法》适用范围

本办法适用于在中华人民共和国境内开展医疗器械(含按照医疗器械管理的体外诊断试剂产品)临床试验的机构备案管理工作。开展医疗器械临床试验的医疗机构和其他承担体外诊断试剂临床试验的血液中心和中心血站、设区的市级以上疾病预防控制中心、戒毒中心等非医疗机构应当按照本办法实行备案。

三、《备案办法》主要内容

《备案办法》分为总则、备案条件、备案程序、监督管理和附则五章共二十条。

总体要求,明确了目的、定义和适用范围,适用于在我国境内开展医疗器械临床试验的临床试验机构备案。

备案条件,明确了医疗机构备案应当具备的条件等相关要求;为了加强对高风险医疗器械管理,保证受试者安全和提高临床试验质量,规定对列入需进行临床试验审批目录的第三类产品,应当在三级甲等医疗机构专业范围内开展临床试验;规定开展创新医疗器械产品或需进行临床试验审批的第三类医疗器械产品临床试验的主要研究者应具有高级技术职称并且参加过3个以上医疗器械或药物临床试验等等。

备案程序,由食品药品监管总局组织建立医疗器械临床试验机构备案管理信息系统(以下简称备案系统);医疗器械临床试验机构办理备案获得备案号后可以承担医疗器械临床试验。

监督管理,明确了省级以上食品药品监管部门和卫生计生行政部门按照分工负责组织开展对临床试验机构的监督管理和信息沟通等职责。

四、备案系统管理工作

备案系统是用于医疗器械临床试验机构进行医疗器械临床试验登记备案、食品药品监管部门和卫生计生行政部门管理临床试验备案的信息平台,由食品药品监管总局组织建立,日常管理工作由食品药品监管总局核查中心负责。备案系统在食品药品监管总局网站(网址http://www.cfda.gov.cn)“网上办事”栏目中,医疗器械临床试验机构应在备案系统中按照有关要求办理备案,公众可以登录备案系统查询已备案的医疗器械临床试验机构名单、专业及联系方式等内容。

五、关于过渡期安排

为了保证临床试验工作的持续开展,自2018年1月1日至2018年12月31日,医疗器械临床试验申办者可以继续选择经食品药品监管总局会同国家卫生计生委认定的药物临床试验机构开展临床试验。其中,体外诊断试剂临床试验申办者还可以继续按照《食品药品监管总局关于实施〈医疗器械注册管理办法〉和〈体外诊断试剂注册管理办法〉有关事项的通知》(食药监械管〔2014〕144号)中的有关规定,选择省级卫生医疗机构开展临床试验;对于特殊使用目的体外诊断试剂,可以在符合要求的市级以上的疾病预防控制中心、专科医院或检验检疫所、戒毒中心等机构开展临床试验。

自2019年1月1日起,医疗器械(包括体外诊断试剂)临床试验申办者应当选取已经在备案系统备案的医疗器械临床试验机构,按照《医疗器械临床试验质量管理规范》(食品药品监管总局 国家卫生计生委令第25号)和《体外诊断试剂注册管理办法》(食品药品监管总局令第5号)的有关要求开展临床试验。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2010989, encodeId=a3332010989a5, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Jun 05 16:40:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955887, encodeId=9b51195588eb2, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Feb 06 05:40:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264932, encodeId=b2c3264932d0, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Nov 28 06:09:34 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590930, encodeId=91e0159093049, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Nov 27 05:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264215, encodeId=50a2264215d8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 25 16:45:51 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
    2018-06-05 yahu
  2. [GetPortalCommentsPageByObjectIdResponse(id=2010989, encodeId=a3332010989a5, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Jun 05 16:40:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955887, encodeId=9b51195588eb2, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Feb 06 05:40:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264932, encodeId=b2c3264932d0, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Nov 28 06:09:34 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590930, encodeId=91e0159093049, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Nov 27 05:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264215, encodeId=50a2264215d8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 25 16:45:51 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2010989, encodeId=a3332010989a5, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Jun 05 16:40:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955887, encodeId=9b51195588eb2, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Feb 06 05:40:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264932, encodeId=b2c3264932d0, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Nov 28 06:09:34 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590930, encodeId=91e0159093049, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Nov 27 05:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264215, encodeId=50a2264215d8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 25 16:45:51 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
    2017-11-28 1e145228m78(暂无匿称)

    学习了谢谢作者分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2010989, encodeId=a3332010989a5, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Jun 05 16:40:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955887, encodeId=9b51195588eb2, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Feb 06 05:40:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264932, encodeId=b2c3264932d0, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Nov 28 06:09:34 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590930, encodeId=91e0159093049, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Nov 27 05:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264215, encodeId=50a2264215d8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 25 16:45:51 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
    2017-11-27 hb2008ye
  5. [GetPortalCommentsPageByObjectIdResponse(id=2010989, encodeId=a3332010989a5, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Jun 05 16:40:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955887, encodeId=9b51195588eb2, content=<a href='/topic/show?id=82e6e602651' target=_blank style='color:#2F92EE;'>#管理办法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76026, encryptionId=82e6e602651, topicName=管理办法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b1f500, createdName=zengjiayao, createdTime=Tue Feb 06 05:40:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264932, encodeId=b2c3264932d0, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Nov 28 06:09:34 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590930, encodeId=91e0159093049, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Nov 27 05:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264215, encodeId=50a2264215d8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 25 16:45:51 CST 2017, time=2017-11-25, status=1, ipAttribution=)]
    2017-11-25 Y—xianghai

    学习了新知识

    0

相关资讯

近期医药行业重要政策解读及市场趋势分析

第77届全国药品交易会和2017中国健康营养博览会于2017年5月16在上海国家会展中心隆重开幕,除了展会现场展示的医药制剂、健康产品及相关技术、服务,现场还有将近40场会议论坛,覆盖政策、营销、市场、医药电商、技术交易等行业热点,可谓大咖云集,精彩纷呈。5月17日上午小编有幸参加了2016中国医药市场信息发布会,在发布会上,国药控股高级行业研究员干荣富做了精彩的演讲报告,主题是“近期医药行业